Clearside Biomedical (NASDAQ:CLSD) Downgraded by StockNews.com to “Sell”
StockNews.com downgraded shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Other equities analysts have also recently issued reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $6.00 target price on shares of Clearside […]
StockNews.com downgraded shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Other equities analysts have also recently issued reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $6.00 target price on shares of Clearside […]
